ICD120K ;ALB/RFS - YEARLY DRG UPDATE; August 15, 2024@15:24
;;18.0;DRG Grouper;**120**;October 20, 2000;Build 4
;Per VA Directive 6402, this routine should not be modified.
;Updates for DRGS 810-END
Q
;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS
;;810^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITHOUT CC/MCC^0.9517^2.5^3.1
;;811^16^MED^RED BLOOD CELL DISORDERS WITH MCC^1.4068^3.7^5
;;812^16^MED^RED BLOOD CELL DISORDERS WITHOUT MCC^0.9229^2.8^3.6
;;813^16^MED^COAGULATION DISORDERS^1.5479^3.6^4.8
;;814^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH MCC^2.0903^5^7.4
;;815^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH CC^1.0161^3^3.9
;;816^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITHOUT CC/MCC^0.6594^2.1^2.5
;;817^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITH MCC^2.1857^4.2^7.4
;;818^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITH CC^0.9893^2.3^2.7
;;819^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITHOUT CC/MCC^0.6753^1.6^1.8
;;820^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH MCC^5.8219^11.1^15.7
;;821^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH CC^2.2322^3.5^5.3
;;822^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC^1.1436^1.5^1.8
;;823^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH MCC^4.6792^10.5^14.1
;;824^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH CC^2.1993^5^6.8
;;825^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITHOUT CC/MCC^1.2307^2.2^2.9
;;826^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH MCC^4.7752^9^11.9
;;827^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH CC^2.3597^4.1^5.4
;;828^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC^1.6028^2.4^2.9
;;829^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITH CC/MCC^3.0836^6^8.9
;;830^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITHOUT CC/MCC^1.4624^2.1^2.7
;;831^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITH MCC^1.1509^3.4^4.7
;;832^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITH CC^0.7473^2.6^3.9
;;833^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITHOUT CC/MCC^0.5198^1.7^2.4
;;834^17^MED^ACUTE LEUKEMIA WITH MCC^5.5269^9.4^15.5
;;835^17^MED^ACUTE LEUKEMIA WITH CC^2.1358^4.4^7
;;836^17^MED^ACUTE LEUKEMIA WITHOUT CC/MCC^1.2423^2.4^3.8
;;837^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC^5.0068^10.4^15.5
;;838^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT^2.0281^5.2^6.7
;;839^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC^1.3703^3.9^4.4
;;840^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MCC^3.1894^6.7^9.6
;;841^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH CC^1.5679^3.9^5.3
;;842^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT CC/MCC^1.0518^2.6^3.4
;;843^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MCC^1.8931^5.4^7.4
;;844^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH CC^1.1951^3.7^5
;;845^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITHOUT CC/MCC^0.8367^2.4^3.2
;;846^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC^2.5536^6^7.9
;;847^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC^1.2706^3.9^4.4
;;848^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC^0.8189^2.7^3.1
;;849^17^MED^RADIOTHERAPY^2.6709^7.4^9.7
;;850^17^SURG^ACUTE LEUKEMIA WITH OTHER PROCEDURES^9.2113^15.9^24
;;853^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC^5.0015^9.6^12.9
;;854^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH CC^1.9982^5^6.3
;;855^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITHOUT CC/MCC^1.6255^3.3^4.2
;;856^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITH MCC^4.5113^9.2^12.3
;;857^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITH CC^2.1789^5.4^6.7
;;858^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITHOUT CC/MCC^1.2884^3.3^4
;;862^18^MED^POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITH MCC^1.8386^5.1^6.7
;;863^18^MED^POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITHOUT MCC^0.9999^3.4^4.3
;;864^18^MED^FEVER AND INFLAMMATORY CONDITIONS^0.8979^2.7^3.4
;;865^18^MED^VIRAL ILLNESS WITH MCC^1.4504^4^5.5
;;866^18^MED^VIRAL ILLNESS WITHOUT MCC^0.8847^2.7^3.6
;;867^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH MCC^2.1442^5.4^7.4
;;868^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH CC^1.05^3.4^4.3
;;869^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITHOUT CC/MCC^0.7195^2.4^2.8
;;870^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS^6.9565^12.8^15.4
;;871^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MCC^1.9623^4.9^6.6
;;872^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC^1.031^3.5^4.2
;;876^19^SURG^O.R. PROCEDURES WITH PRINCIPAL DIAGNOSIS OF MENTAL ILLNESS^3.9294^7.4^18.1
;;880^19^MED^ACUTE ADJUSTMENT REACTION AND PSYCHOSOCIAL DYSFUNCTION^0.9586^2.8^4.2
;;881^19^MED^DEPRESSIVE NEUROSES^0.9141^4^5.9
;;882^19^MED^NEUROSES EXCEPT DEPRESSIVE^0.9619^3.4^5.1
;;883^19^MED^DISORDERS OF PERSONALITY AND IMPULSE CONTROL^1.8564^5.8^11.9
;;884^19^MED^ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY^1.6701^4.7^8.3
;;885^19^MED^PSYCHOSES^1.4095^6.5^9.9
;;886^19^MED^BEHAVIORAL AND DEVELOPMENTAL DISORDERS^1.7964^4.6^11.7
;;887^19^MED^OTHER MENTAL DISORDER DIAGNOSES^1.1893^3.3^5.6
;;894^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE, LEFT AMA^0.6241^2.1^2.9
;;895^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITH REHABILITATION THERAPY^1.4032^7.6^10.6
;;896^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITH MCC^1.7808^4.8^7
;;897^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MCC^0.8822^3.3^4.3
;;901^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITH MCC^4.4302^9.1^13.9
;;902^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITH CC^1.8974^4.5^6.3
;;903^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITHOUT CC/MCC^1.219^2.6^3.4
;;904^21^SURG^SKIN GRAFTS FOR INJURIES WITH CC/MCC^3.8609^7^10.5
;;905^21^SURG^SKIN GRAFTS FOR INJURIES WITHOUT CC/MCC^1.6481^2.9^3.8
;;906^21^SURG^HAND PROCEDURES FOR INJURIES^2.1824^3.2^5.8
;;907^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITH MCC^3.9835^6.9^9.9
;;908^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITH CC^2.017^3.7^4.9
;;909^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITHOUT CC/MCC^1.2682^2.1^2.6
;;913^21^MED^TRAUMATIC INJURY WITH MCC^1.6182^3.8^5.7
;;914^21^MED^TRAUMATIC INJURY WITHOUT MCC^0.9163^2.6^3.4
;;915^21^MED^ALLERGIC REACTIONS WITH MCC^1.7378^3.7^5.2
;;916^21^MED^ALLERGIC REACTIONS WITHOUT MCC^0.664^1.8^2.2
;;917^21^MED^POISONING AND TOXIC EFFECTS OF DRUGS WITH MCC^1.6396^3.8^5.6
;;918^21^MED^POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MCC^0.8844^2.5^3.5
;;919^21^MED^COMPLICATIONS OF TREATMENT WITH MCC^1.8234^4.4^6.1
;;920^21^MED^COMPLICATIONS OF TREATMENT WITH CC^1.0158^2.9^3.7
;;921^21^MED^COMPLICATIONS OF TREATMENT WITHOUT CC/MCC^0.6876^2.1^2.6
;;922^21^MED^OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITH MCC^1.6892^4.3^7.2
;;923^21^MED^OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITHOUT MCC^1.0198^2.9^4.8
;;927^22^SURG^EXTENSIVE BURNS OR FULL THICKNESS BURNS WITH MV >96 HOURS WITH SKIN GRAFT^20.1109^24^31.7
;;928^22^SURG^FULL THICKNESS BURN WITH SKIN GRAFT OR INHALATION INJURY WITH CC/MCC^6.6785^12.5^17.2
;;929^22^SURG^FULL THICKNESS BURN WITH SKIN GRAFT OR INHALATION INJURY WITHOUT CC/MCC^3.1802^5.9^7.8
;;933^22^MED^EXTENSIVE BURNS OR FULL THICKNESS BURNS WITH MV >96 HOURS WITHOUT SKIN GRAFT^4.3267^2.6^8.4
;;934^22^MED^FULL THICKNESS BURN WITHOUT SKIN GRAFT OR INHALATION INJURY^2.1457^4.4^6.5
;;935^22^MED^NON-EXTENSIVE BURNS^2.1963^4^6.3
;;939^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITH MCC^3.1738^6.3^9.3
;;940^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITH CC^2.1113^3^4.3
;;941^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITHOUT CC/MCC^1.9542^1.9^2.5
;;945^23^MED^REHABILITATION WITH CC/MCC^1.5264^5.1^7.2
;;946^23^MED^REHABILITATION WITHOUT CC/MCC^1.1164^3.6^4.9
;;947^23^MED^SIGNS AND SYMPTOMS WITH MCC^1.2861^3.7^5.3
;;948^23^MED^SIGNS AND SYMPTOMS WITHOUT MCC^0.7945^2.6^3.4
;;949^23^MED^AFTERCARE WITH CC/MCC^1.0789^4.4^6.6
;;950^23^MED^AFTERCARE WITHOUT CC/MCC^0.5861^2.9^3.8
;;951^23^MED^OTHER FACTORS INFLUENCING HEALTH STATUS^0.5669^1.8^2.7
;;955^24^SURG^CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA^6.8279^8.8^13.7
;;956^24^SURG^LIMB REATTACHMENT, HIP AND FEMUR PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA^3.8222^6.2^7.9
;;957^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITH MCC^7.4637^9.8^14.1
;;958^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITH CC^4.1095^6.6^8.2
;;959^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITHOUT CC/MCC^2.6437^3.8^4.5
;;963^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITH MCC^2.7166^5.4^8
;;964^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITH CC^1.5002^3.9^5
;;965^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITHOUT CC/MCC^0.9125^2.5^3
;;969^25^SURG^HIV WITH EXTENSIVE O.R. PROCEDURES WITH MCC^6.3239^12.8^17.9
;;970^25^SURG^HIV WITH EXTENSIVE O.R. PROCEDURES WITHOUT MCC^2.6532^6^7.4
;;974^25^MED^HIV WITH MAJOR RELATED CONDITION WITH MCC^2.986^6.9^10.1
;;975^25^MED^HIV WITH MAJOR RELATED CONDITION WITH CC^1.4213^4.3^6
;;976^25^MED^HIV WITH MAJOR RELATED CONDITION WITHOUT CC/MCC^1.0029^3.1^4.1
;;977^25^MED^HIV WITH OR WITHOUT OTHER RELATED CONDITION^1.4418^3.6^5.3
;;981^ ^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH MCC^4.7543^8.7^12.4
;;982^ ^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC^2.4485^4.1^5.8
;;983^ ^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT CC/MCC^1.6681^2^2.7
;;987^ ^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH MCC^3.503^8.2^11.7
;;988^ ^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC^1.716^4.2^5.8
;;989^ ^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT CC/MCC^1.1554^2.2^2.9
;;998^ ^**^PRINCIPAL DIAGNOSIS INVALID AS DISCHARGE DIAGNOSIS^^^
;;999^ ^**^UNGROUPABLE^^^
;;EXIT
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HICD120K 11151 printed Dec 13, 2024@01:47:31 Page 2
ICD120K ;ALB/RFS - YEARLY DRG UPDATE; August 15, 2024@15:24
+1 ;;18.0;DRG Grouper;**120**;October 20, 2000;Build 4
+2 ;Per VA Directive 6402, this routine should not be modified.
+3 ;Updates for DRGS 810-END
+4 QUIT
+5 ;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS
+1 ;;810^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITHOUT CC/MCC^0.9517^2.5^3.1
+2 ;;811^16^MED^RED BLOOD CELL DISORDERS WITH MCC^1.4068^3.7^5
+3 ;;812^16^MED^RED BLOOD CELL DISORDERS WITHOUT MCC^0.9229^2.8^3.6
+4 ;;813^16^MED^COAGULATION DISORDERS^1.5479^3.6^4.8
+5 ;;814^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH MCC^2.0903^5^7.4
+6 ;;815^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITH CC^1.0161^3^3.9
+7 ;;816^16^MED^RETICULOENDOTHELIAL AND IMMUNITY DISORDERS WITHOUT CC/MCC^0.6594^2.1^2.5
+8 ;;817^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITH MCC^2.1857^4.2^7.4
+9 ;;818^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITH CC^0.9893^2.3^2.7
+10 ;;819^14^SURG^OTHER ANTEPARTUM DIAGNOSES WITH O.R. PROCEDURES WITHOUT CC/MCC^0.6753^1.6^1.8
+11 ;;820^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH MCC^5.8219^11.1^15.7
+12 ;;821^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITH CC^2.2322^3.5^5.3
+13 ;;822^17^SURG^LYMPHOMA AND LEUKEMIA WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC^1.1436^1.5^1.8
+14 ;;823^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH MCC^4.6792^10.5^14.1
+15 ;;824^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITH CC^2.1993^5^6.8
+16 ;;825^17^SURG^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH OTHER PROCEDURES WITHOUT CC/MCC^1.2307^2.2^2.9
+17 ;;826^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH MCC^4.7752^9^11.9
+18 ;;827^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH CC^2.3597^4.1^5.4
+19 ;;828^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC^1.6028^2.4^2.9
+20 ;;829^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITH CC/MCC^3.0836^6^8.9
+21 ;;830^17^SURG^MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITHOUT CC/MCC^1.4624^2.1^2.7
+22 ;;831^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITH MCC^1.1509^3.4^4.7
+23 ;;832^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITH CC^0.7473^2.6^3.9
+24 ;;833^14^MED^OTHER ANTEPARTUM DIAGNOSES WITHOUT O.R. PROCEDURES WITHOUT CC/MCC^0.5198^1.7^2.4
+25 ;;834^17^MED^ACUTE LEUKEMIA WITH MCC^5.5269^9.4^15.5
+26 ;;835^17^MED^ACUTE LEUKEMIA WITH CC^2.1358^4.4^7
+27 ;;836^17^MED^ACUTE LEUKEMIA WITHOUT CC/MCC^1.2423^2.4^3.8
+28 ;;837^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC^5.0068^10.4^15.5
+29 ;;838^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT^2.0281^5.2^6.7
+30 ;;839^17^MED^CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC^1.3703^3.9^4.4
+31 ;;840^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MCC^3.1894^6.7^9.6
+32 ;;841^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITH CC^1.5679^3.9^5.3
+33 ;;842^17^MED^LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT CC/MCC^1.0518^2.6^3.4
+34 ;;843^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MCC^1.8931^5.4^7.4
+35 ;;844^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH CC^1.1951^3.7^5
+36 ;;845^17^MED^OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITHOUT CC/MCC^0.8367^2.4^3.2
+37 ;;846^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC^2.5536^6^7.9
+38 ;;847^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC^1.2706^3.9^4.4
+39 ;;848^17^MED^CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC^0.8189^2.7^3.1
+40 ;;849^17^MED^RADIOTHERAPY^2.6709^7.4^9.7
+41 ;;850^17^SURG^ACUTE LEUKEMIA WITH OTHER PROCEDURES^9.2113^15.9^24
+42 ;;853^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC^5.0015^9.6^12.9
+43 ;;854^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH CC^1.9982^5^6.3
+44 ;;855^18^SURG^INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITHOUT CC/MCC^1.6255^3.3^4.2
+45 ;;856^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITH MCC^4.5113^9.2^12.3
+46 ;;857^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITH CC^2.1789^5.4^6.7
+47 ;;858^18^SURG^POSTOPERATIVE OR POST-TRAUMATIC INFECTIONS WITH O.R. PROCEDURES WITHOUT CC/MCC^1.2884^3.3^4
+48 ;;862^18^MED^POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITH MCC^1.8386^5.1^6.7
+49 ;;863^18^MED^POSTOPERATIVE AND POST-TRAUMATIC INFECTIONS WITHOUT MCC^0.9999^3.4^4.3
+50 ;;864^18^MED^FEVER AND INFLAMMATORY CONDITIONS^0.8979^2.7^3.4
+51 ;;865^18^MED^VIRAL ILLNESS WITH MCC^1.4504^4^5.5
+52 ;;866^18^MED^VIRAL ILLNESS WITHOUT MCC^0.8847^2.7^3.6
+53 ;;867^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH MCC^2.1442^5.4^7.4
+54 ;;868^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITH CC^1.05^3.4^4.3
+55 ;;869^18^MED^OTHER INFECTIOUS AND PARASITIC DISEASES DIAGNOSES WITHOUT CC/MCC^0.7195^2.4^2.8
+56 ;;870^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITH MV >96 HOURS^6.9565^12.8^15.4
+57 ;;871^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MCC^1.9623^4.9^6.6
+58 ;;872^18^MED^SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC^1.031^3.5^4.2
+59 ;;876^19^SURG^O.R. PROCEDURES WITH PRINCIPAL DIAGNOSIS OF MENTAL ILLNESS^3.9294^7.4^18.1
+60 ;;880^19^MED^ACUTE ADJUSTMENT REACTION AND PSYCHOSOCIAL DYSFUNCTION^0.9586^2.8^4.2
+61 ;;881^19^MED^DEPRESSIVE NEUROSES^0.9141^4^5.9
+62 ;;882^19^MED^NEUROSES EXCEPT DEPRESSIVE^0.9619^3.4^5.1
+63 ;;883^19^MED^DISORDERS OF PERSONALITY AND IMPULSE CONTROL^1.8564^5.8^11.9
+64 ;;884^19^MED^ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY^1.6701^4.7^8.3
+65 ;;885^19^MED^PSYCHOSES^1.4095^6.5^9.9
+66 ;;886^19^MED^BEHAVIORAL AND DEVELOPMENTAL DISORDERS^1.7964^4.6^11.7
+67 ;;887^19^MED^OTHER MENTAL DISORDER DIAGNOSES^1.1893^3.3^5.6
+68 ;;894^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE, LEFT AMA^0.6241^2.1^2.9
+69 ;;895^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITH REHABILITATION THERAPY^1.4032^7.6^10.6
+70 ;;896^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITH MCC^1.7808^4.8^7
+71 ;;897^20^MED^ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MCC^0.8822^3.3^4.3
+72 ;;901^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITH MCC^4.4302^9.1^13.9
+73 ;;902^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITH CC^1.8974^4.5^6.3
+74 ;;903^21^SURG^WOUND DEBRIDEMENTS FOR INJURIES WITHOUT CC/MCC^1.219^2.6^3.4
+75 ;;904^21^SURG^SKIN GRAFTS FOR INJURIES WITH CC/MCC^3.8609^7^10.5
+76 ;;905^21^SURG^SKIN GRAFTS FOR INJURIES WITHOUT CC/MCC^1.6481^2.9^3.8
+77 ;;906^21^SURG^HAND PROCEDURES FOR INJURIES^2.1824^3.2^5.8
+78 ;;907^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITH MCC^3.9835^6.9^9.9
+79 ;;908^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITH CC^2.017^3.7^4.9
+80 ;;909^21^SURG^OTHER O.R. PROCEDURES FOR INJURIES WITHOUT CC/MCC^1.2682^2.1^2.6
+81 ;;913^21^MED^TRAUMATIC INJURY WITH MCC^1.6182^3.8^5.7
+82 ;;914^21^MED^TRAUMATIC INJURY WITHOUT MCC^0.9163^2.6^3.4
+83 ;;915^21^MED^ALLERGIC REACTIONS WITH MCC^1.7378^3.7^5.2
+84 ;;916^21^MED^ALLERGIC REACTIONS WITHOUT MCC^0.664^1.8^2.2
+85 ;;917^21^MED^POISONING AND TOXIC EFFECTS OF DRUGS WITH MCC^1.6396^3.8^5.6
+86 ;;918^21^MED^POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MCC^0.8844^2.5^3.5
+87 ;;919^21^MED^COMPLICATIONS OF TREATMENT WITH MCC^1.8234^4.4^6.1
+88 ;;920^21^MED^COMPLICATIONS OF TREATMENT WITH CC^1.0158^2.9^3.7
+89 ;;921^21^MED^COMPLICATIONS OF TREATMENT WITHOUT CC/MCC^0.6876^2.1^2.6
+90 ;;922^21^MED^OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITH MCC^1.6892^4.3^7.2
+91 ;;923^21^MED^OTHER INJURY, POISONING AND TOXIC EFFECT DIAGNOSES WITHOUT MCC^1.0198^2.9^4.8
+92 ;;927^22^SURG^EXTENSIVE BURNS OR FULL THICKNESS BURNS WITH MV >96 HOURS WITH SKIN GRAFT^20.1109^24^31.7
+93 ;;928^22^SURG^FULL THICKNESS BURN WITH SKIN GRAFT OR INHALATION INJURY WITH CC/MCC^6.6785^12.5^17.2
+94 ;;929^22^SURG^FULL THICKNESS BURN WITH SKIN GRAFT OR INHALATION INJURY WITHOUT CC/MCC^3.1802^5.9^7.8
+95 ;;933^22^MED^EXTENSIVE BURNS OR FULL THICKNESS BURNS WITH MV >96 HOURS WITHOUT SKIN GRAFT^4.3267^2.6^8.4
+96 ;;934^22^MED^FULL THICKNESS BURN WITHOUT SKIN GRAFT OR INHALATION INJURY^2.1457^4.4^6.5
+97 ;;935^22^MED^NON-EXTENSIVE BURNS^2.1963^4^6.3
+98 ;;939^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITH MCC^3.1738^6.3^9.3
+99 ;;940^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITH CC^2.1113^3^4.3
+100 ;;941^23^SURG^O.R. PROCEDURES WITH DIAGNOSES OF OTHER CONTACT WITH HEALTH SERVICES WITHOUT CC/MCC^1.9542^1.9^2.5
+101 ;;945^23^MED^REHABILITATION WITH CC/MCC^1.5264^5.1^7.2
+102 ;;946^23^MED^REHABILITATION WITHOUT CC/MCC^1.1164^3.6^4.9
+103 ;;947^23^MED^SIGNS AND SYMPTOMS WITH MCC^1.2861^3.7^5.3
+104 ;;948^23^MED^SIGNS AND SYMPTOMS WITHOUT MCC^0.7945^2.6^3.4
+105 ;;949^23^MED^AFTERCARE WITH CC/MCC^1.0789^4.4^6.6
+106 ;;950^23^MED^AFTERCARE WITHOUT CC/MCC^0.5861^2.9^3.8
+107 ;;951^23^MED^OTHER FACTORS INFLUENCING HEALTH STATUS^0.5669^1.8^2.7
+108 ;;955^24^SURG^CRANIOTOMY FOR MULTIPLE SIGNIFICANT TRAUMA^6.8279^8.8^13.7
+109 ;;956^24^SURG^LIMB REATTACHMENT, HIP AND FEMUR PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA^3.8222^6.2^7.9
+110 ;;957^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITH MCC^7.4637^9.8^14.1
+111 ;;958^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITH CC^4.1095^6.6^8.2
+112 ;;959^24^SURG^OTHER O.R. PROCEDURES FOR MULTIPLE SIGNIFICANT TRAUMA WITHOUT CC/MCC^2.6437^3.8^4.5
+113 ;;963^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITH MCC^2.7166^5.4^8
+114 ;;964^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITH CC^1.5002^3.9^5
+115 ;;965^24^MED^OTHER MULTIPLE SIGNIFICANT TRAUMA WITHOUT CC/MCC^0.9125^2.5^3
+116 ;;969^25^SURG^HIV WITH EXTENSIVE O.R. PROCEDURES WITH MCC^6.3239^12.8^17.9
+117 ;;970^25^SURG^HIV WITH EXTENSIVE O.R. PROCEDURES WITHOUT MCC^2.6532^6^7.4
+118 ;;974^25^MED^HIV WITH MAJOR RELATED CONDITION WITH MCC^2.986^6.9^10.1
+119 ;;975^25^MED^HIV WITH MAJOR RELATED CONDITION WITH CC^1.4213^4.3^6
+120 ;;976^25^MED^HIV WITH MAJOR RELATED CONDITION WITHOUT CC/MCC^1.0029^3.1^4.1
+121 ;;977^25^MED^HIV WITH OR WITHOUT OTHER RELATED CONDITION^1.4418^3.6^5.3
+122 ;;981^ ^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH MCC^4.7543^8.7^12.4
+123 ;;982^ ^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC^2.4485^4.1^5.8
+124 ;;983^ ^SURG^EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT CC/MCC^1.6681^2^2.7
+125 ;;987^ ^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH MCC^3.503^8.2^11.7
+126 ;;988^ ^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC^1.716^4.2^5.8
+127 ;;989^ ^SURG^NON-EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITHOUT CC/MCC^1.1554^2.2^2.9
+128 ;;998^ ^**^PRINCIPAL DIAGNOSIS INVALID AS DISCHARGE DIAGNOSIS^^^
+129 ;;999^ ^**^UNGROUPABLE^^^
+130 ;;EXIT